ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

NIH Construction: Clinton, NIH Officials Dedicate Vaccine Research Center

June 11, 1999

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

Shubik applauded for NCAB Service

February 12, 1982

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005